Showing results (221-230 of 232) with videos related to

Sort By:
Pageof 24
Circulation Research|July 17, 2019
Physiological Biomimetic Culture System for Pig and Human Heart SlicesQinghui Ou, Zoë Jacobson, Riham R E Abouleisa, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 20, 2018
Guidelines for experimental models of myocardial ischemia and infarctionMerry L Lindsey, Roberto Bolli, John M Canty, et al.
American Heart Journal|June 19, 2018
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) TrialRoberto Bolli, Joshua M Hare, Timothy D Henry, et al.
American Heart Journal|September 7, 2016
Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trialAruni Bhatnagar, Roberto Bolli, Brian H Johnstone, et al.
Circulation Research|April 29, 2018
Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit+ Cardiac Stem Cells As Regenerative Therapy for Heart Failure)Roberto Bolli, Joshua M Hare, Keith L March, et al.
Cell Transplantation|November 22, 2015
Identification of Bone Marrow Cell Subpopulations Associated With Improved Functional Outcomes in Patients With Chronic Left Ventricular Dysfunction: An Embedded Cohort Evaluation of the FOCUS-CCTRN TrialDoris A Taylor, Emerson C Perin, James T Willerson, et al.
Circulation|January 21, 2022
Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart FailureRiham R E Abouleisa, Abou Bakr M Salama, Qinghui Ou, et al.
Circulation Research|August 20, 2014
Detailed analysis of bone marrow from patients with ischemic heart disease and left ventricular dysfunction: BM CD34, CD11b, and clonogenic capacity as biomarkers for clinical outcomesChristopher R Cogle, Elizabeth Wise, Amy M Meacham, et al.
Circulation Research|January 4, 2019
Convergences of Life Sciences and Engineering in Understanding and Treating Heart FailureJoel L Berry, Wuqiang Zhu, Yao Liang Tang, et al.
JACC. Cardiooncology|January 6, 2021
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA TrialRoberto Bolli, Emerson C Perin, James T Willerson, et al.
Pageof 24